跳至主要内容
临床试验/CTRI/2020/05/025469
CTRI/2020/05/025469尚未招募未知

Comparison of efficacy of levonorgestrel intrauterine sytem (LNG-IUS) versus norethisterone acetate (NETA) in medical management of abnormal uterine bleeding (AUB) a non randomized intervention trial

AIIMS rishikesh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women having AUB of age group 35-50 years attending Gynaecology OPD
  • With uterine size less than or equal to 12 weeks with no cervical, vaginal
  • pathologies and negative pap smear.
  • Histopathological report negative for malignancy.
  • in case of LNG-IUS group who require contraception

排除标准

  • Women with congenital anomalies or acquired uterine anomaly, intramural
  • and subserous fibroid >3 cm and submucous fibroids distorting uterine cavity,
  • acute pelvic inflammatory disease, genital bleeding of unknown aetiology,
  • liver disease, and known or suspected carcinoma of breast.
  • 2) Women not giving consent
  • 3) Women wishing for surgical management.
  • 4) Women diagnosed with endometrial cancer.
  • 5) Women EH with atypia, age >50 years, other pathology e.g., submucosal
  • myomas or polyps, adnexal abnormality, genital infection, hormone therapy or
  • any medication which might affect the menstrual blood loss , steroid
  • hormones or anticoagulants, previous endometrial ablation, diabetic and/or
  • hypertensive patients and
  • 6) The patients who have thromboembolism, pregnancy, submucosal myoma
  • having component inside the cavity over 50% and myomas bigger then 5 cm
  • are excluded.
  • 7) Not willing for medical management
  • 8)tubectomised (bilateral tubal ligated)

研究者

相似试验